HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combinat...

por Valdez, Benigno C., Nieto, Yago, Yuan, Bin, Murray, David, Andersson, Borje S.
Publicado 2022

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells

por Valdez, Benigno C., Murray, David, Yuan, Bin, Nieto, Yago, Popat, Uday, Andersson, Borje S.
Publicado 2022

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective

por Sheikh, Irtiza N., Elgehiny, Amr, Ragoonanan, Dristhi, Mahadeo, Kris M., Nieto, Yago, Khazal, Sajad
Publicado 2022

Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis...

por Valdez, Benigno C., Li, Yang, Murray, David, Liu, Yan, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Publicado 2017

Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

por Roldan, Carlos J., Huh, Billy, Song, Juhee, Nieto, Yago, Osei, Joyce, Chai, Thomas, Nouri, Kent, Koyyalagunta, Lakshmi, Bruera, Eduardo
Publicado 2022

Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy

por Valdez, Benigno C., Li, Yang, Murray, David, Brammer, Jonathan E., Liu, Yan, Hosing, Chitra, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Publicado 2016

288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib

por Malek, Alexandre, Nieto, Yago, Szvalb, Ariel D, Siddiqui, Shaheer, Shafi, Mehnaz A, Hwang, Jessica P, Raad, Issam I, Torres, Harrys A
Publicado 2019

Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports

por Milgrom, Sarah A., Nieto, Yago, Pinnix, Chelsea C., Smith, Grace L., Wogan, Christine F., Rondon, Gabriela, Medeiros, L. Jeffrey, Kebriaei, Partow, Dabaja, Bouthaina S.
Publicado 2016

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

por Mego, Michal, Gao, Hui, Lee, Bang-Ning, Cohen, Evan N., Tin, Sanda, Giordano, Antonio, Wu, Qiong, Liu, Ping, Nieto, Yago, Champlin, Richard E., Hortobagyi, Gabriel N., Cristofanilli, Massimo, Ueno, Naoto T., Reuben, James M.
Publicado 2012

Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant

por Nieto, Yago, Pasvolsky, Oren, Bassett, Roland, Ghanem, Sassine, Cuglievan, Branko, Tewari, Priti, HOSING, CHITRA, Srour, Samer, Ramdial, Jeremy, Mahadeo, Kris, Khazal, Sajad, Petropoulos, Demetrios, Popat, Uday, Qazilbash, Muzaffar, Kebriaei, Partow, Champlin, Richard, Shpall, Elizabeth
Publicado 2023

Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantati...

por Cheng, Yee Chung, Shi, Yushu, Zhang, Mei-Jie, Brazauskas, Ruta, Hemmer, Michael T., Bishop, Michael R., Nieto, Yago, Stadtmauer, Edward, Ayash, Lois, Gale, Robert Peter, Lazarus, Hillard, Holmberg, Leona, Lill, Michael, Olsson, Richard F., Wirk, Baldeep Mona, Arora, Mukta, Hari, Parameswaran, Ueno, Naoto
Publicado 2017

Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma

por Youssef, Bassem, Shank, JoAnn, Reddy, Jay P., Pinnix, Chelsea C., Farha, George, Akhtari, Mani, Allen, Pamela K., Fanale, Michelle A., Garcia, John A., Horace, Patricia H., Milgrom, Sarah, Smith, Grace Li, Nieto, Yago, Arzu, Isadora, Wang, He, Fowler, Nathan, Rodriguez, Maria Alma, Dabaja, Bouthaina
Publicado 2015

Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan

por Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar
Publicado 2017

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

por Sheu, Tommy, Milgrom, Sarah A., Andraos, Therese Y., Gunther, Jillian R., Chi, Linda, Nastoupil, Loretta, Fowler, Nathan, Oki, Yasuhiro, Fanale, Michelle A., Fayad, Luis E., Hagemeister, Fredrick, Neelapu, Sattva S., Medeiros, L. Jeffrey, Hosing, Chitra, Nieto, Yago, Ahmed, Sairah, Alousi, Amin M., Dabaja, Bouthaina, Pinnix, Chelsea C.
Publicado 2018

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety...

por Kellner, Joshua N., Delemarre, Eveline M., Yvon, Eric, Nierkens, Stefan, Boelens, Jaap J., McNiece, Ian, Olson, Amanda, Nieto, Yago, Ciurea, Stefan, Popat, Uday, Ahmed, Sairah, Champlin, Richard, Ramos, Jennifer, Nishimoto, Mitsutaka, Ma, Hongbing, Ke, Zeng, Thall, Peter, Khoury, Joseph D., Negrin, Robert, Andersson, Borje, Parmar, Simrit
Publicado 2018

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma

por Srour, Samer A., Milton, Denái R., Bashir, Qaiser, Nieto, Yago, Saini, Neeraj, Daher, May, Ramdial, Jeremy, Im, Jin, Hosing, Chitra, Delgado, Ruby, Manasanch, Elisabet, Lee, Hans C., Thomas, Sheeba, Kaufman, Gregory, Patel, Krina, Popat, Uday, Weber, Donna, Orlowski, Robert, Shpall, Elizabeth, Champlin, Richard E., Qazilbash, Muzaffar H.
Publicado 2021

P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES

por Pasvolsky, Oren, Ghanem, Sassine, Milton, Denái R., Masood, Adeel, Tanner, Mark R., Bashir, Qaiser, Srour, Samer, Saini, Neeraj, Ramdial, Jeremy L., Nieto, Yago, Lee, Hans C., Patel, Krina K., Kebriaei, Partow, Thomas, Sheeba K., Weber, Donna M., Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H.
Publicado 2023

A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

por Popat, Uday R., Andersson, Borje S., Bassett, Roland, Kawedia, Jitesh, Valdez, Ben C., Alousi, Amin M., Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra M., Im, Jin S., Kebriaei, Partow, Marin, David, Nieto, Yago, Oran, Betul, Olson, Amanda, Qazilbash, Muzaffar H., Srour, Samer A., Shpall, Elizabeth J., Champlin, Richard E., Mehta, Rohtesh S.
Publicado 2022

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

por Jallouk, Andrew P., Gouni, Sushanth, Westin, Jason, Feng, Lei, Mistry, Haleigh, Steiner, Raphael E., James, Jinsu, Noorani, Mansoor, Horowitz, Sandra, Puebla-Osorio, Nahum, Fayad, Luis E., Iyer, Swaminathan P., Hawkins, Misha, Flowers, Christopher R., Ahmed, Sairah, Nastoupil, Lo retta J, Kebriaei, Partow, Shpall, Elizabeth J., Neelapu, Sattva S., Nieto, Yago, Strati, Paolo
Publicado 2022

Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

por Bashir, Qaiser, Milton, Denái R., Popat, Uday R., Kebriaei, Partow, Hosing, Chitra, Khouri, Issa F., Rezvani, Katayoun, Nieto, Yago, Oran, Betul, Srour, Samer A., Saini, Neeraj Y., Olson, Amanda L., Ahmed, Sairah, Al-Atrash, Gheath, Rondon, Gabriela, Konopleva, Marina Y., Champlin, Richard E., Shpall, Elizabeth J., Qazilbash, Muzaffar H., Pemmaraju, Naveen
Publicado 2022